Resilience for Young People With Attention Deficit Hyperactivity Disorder (ADHD) - a Randomized Controlled Trial of a Brief Intervention Program.
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- University of Aarhus
- Enrollment
- 8,000
- Locations
- 1
- Primary Endpoint
- Adult ADHD Self-Report Scale (ASRS-v1.1)
Study Overview
Brief Summary
In this project we invite 8.000 young persons (age 18-27) in Denmark and to participate in a randomized controlled intervention study where we aim to test the effectiveness of a web based knowledge and inspiration program about resilience for children, adolescents and adults (called myresilience.org). The complete CONSORT trial protocol is available at http://myresilience.org/ at the subsite 'about us'.
Detailed Description
The complete CONSORT trial protocol is available at http://myresilience.org/ at the subsite 'about us'.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Prevention
- Masking
- Double (Participant, Outcomes Assessor)
Eligibility Criteria
- Ages
- 18 Years to 27 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •A random sample with 8.000 patients registered in the Danish National Patient Register:
- •Age 18-27
- •ADHD diagnosis
Exclusion Criteria
- •Request for legal protection against contacts from researchers.
Arms & Interventions
Control
Service as usual
Intervention group
Participants are offered access to the web based resilience program and are invited to join a short introduction course.
Intervention: The Resilience Program (Behavioral)
Outcomes
Primary Outcomes
Adult ADHD Self-Report Scale (ASRS-v1.1)
Time Frame: Follow-up will be on the average 1 year after intervention
The Symptom Checklist is an instrument consisting of the eighteen Diagnostic and Statistical Manual criteria (DSM-IV). Six of the eighteen questions were found to be the most predictive of symptoms consistent with ADHD. These six questions are the basis for the ASRS v1.1. The measure is a number score. The ASRS-v1.1 will be administered to all participants before and 1 year after the intervention.
Secondary Outcomes
- The 12-item General Health Questionnaire (GHQ-12)(Follow-up will be on the average 1 year after intervention)